Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by First Affirmative Financial Network

First Affirmative Financial Network reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the 4th quarter, HoldingsChannel reports. The firm owned 986 shares of the medical equipment provider’s stock after selling 30 shares during the period. First Affirmative Financial Network’s holdings in Intuitive Surgical were worth $515,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of ISRG. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at $26,000. Godsey & Gibb Inc. boosted its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical during the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical in the third quarter valued at about $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent analyst reports. Robert W. Baird boosted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Piper Sandler reissued an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Barclays upped their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday. Finally, BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling

In other news, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 28,843 shares of company stock worth $15,357,560. 0.90% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $572.71 on Thursday. The firm’s 50-day moving average is $548.70 and its two-hundred day moving average is $507.04. The stock has a market capitalization of $203.99 billion, a P/E ratio of 92.08, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.